These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36257368)

  • 21. MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.
    Trinczek B; Brajenovic M; Ebneth A; Drewes G
    J Biol Chem; 2004 Feb; 279(7):5915-23. PubMed ID: 14594945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4.
    Anwar S; Khan S; Anjum F; Shamsi A; Khan P; Fatima H; Shafie A; Islam A; Hassan MI
    J Cell Biochem; 2022 Feb; 123(2):359-374. PubMed ID: 34751461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression.
    Naz F; Khan FI; Mohammad T; Khan P; Manzoor S; Hasan GM; Lobb KA; Luqman S; Islam A; Ahmad F; Hassan MI
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2580-2589. PubMed ID: 29079437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human microtubule affinity-regulating kinase 4 is stable at extremes of pH.
    Naz F; Singh P; Islam A; Ahmad F; Imtaiyaz Hassan M
    J Biomol Struct Dyn; 2016 Jun; 34(6):1241-51. PubMed ID: 26208600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic targeting of microtubule affinity-regulating kinase 4 in cancer and neurodegenerative diseases.
    Alam M; Ahmed S; Abid M; Hasan GM; Islam A; Hassan MI
    J Cell Biochem; 2023 Sep; 124(9):1223-1240. PubMed ID: 37661636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An identification of MARK inhibitors using high throughput MALDI-TOF mass spectrometry.
    Hruba L; Polishchuk P; Das V; Hajduch M; Dzubak P
    Biomed Pharmacother; 2022 Feb; 146():112549. PubMed ID: 34923338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy.
    Anwar S; Shahwan M; Hasan GM; Islam A; Hassan MI
    Cell Signal; 2022 Nov; 99():110434. PubMed ID: 35961526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262.
    Saito T; Oba T; Shimizu S; Asada A; Iijima KM; Ando K
    Hum Mol Genet; 2019 Sep; 28(18):3062-3071. PubMed ID: 31174206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the most promising anti - Depressant drug targeting Microtubule Affinity Receptor Kinase 4 involved in Alzheimer's Disease through molecular docking and molecular dynamics simulation.
    Ahmad SR; Zeyaullah M; AlShahrani AM; Khan MS; Muzammil K; Ahmed F; Dawria A; Mohieldin A; Ali H; Altijani AAG
    PLoS One; 2024; 19(7):e0301179. PubMed ID: 39052643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and dynamics of inactive and active MARK4: conformational switching through the activation process.
    Ahrari S; Mogharrab N; Navapour L
    J Biomol Struct Dyn; 2020 May; 38(8):2468-2481. PubMed ID: 31411112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of lisinopril in the therapeutic management of cardiovascular disease by targeting microtubule affinity regulating kinase 4: molecular docking and molecular dynamics simulation approaches.
    Atiya A; Alsayari A; Bin Muhsinah A; Almaghaslah D; Bilgrami AL; Abdulmonem WA; Alorfi NM; DasGupta D; Ashraf GM; Shamsi A; Shahwan M
    J Biomol Struct Dyn; 2023; 41(18):8824-8830. PubMed ID: 36376029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linagliptin and Empagliflozin Inhibit Microtubule Affinity Regulatory Kinase 4: Repurposing Anti-Diabetic Drugs in Neurodegenerative Disorders Using In Silico and In Vitro Approaches.
    Atiya A; Das Gupta D; Alsayari A; Alrouji M; Alotaibi A; Sharaf SE; Abdulmonem WA; Alorfi NM; Abdullah KM; Shamsi A
    ACS Omega; 2023 Feb; 8(7):6423-6430. PubMed ID: 36844587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer's disease treatment.
    Sun W; Lee S; Huang X; Liu S; Inayathullah M; Kim KM; Tang H; Ashford JW; Rajadas J
    Sci Rep; 2016 Oct; 6():34784. PubMed ID: 27708431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies.
    Khan P; Rahman S; Queen A; Manzoor S; Naz F; Hasan GM; Luqman S; Kim J; Islam A; Ahmad F; Hassan MI
    Sci Rep; 2017 Aug; 7(1):9470. PubMed ID: 28842631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cell-penetrating peptide derived from SARS-CoV-2 protein Orf9b allosterically inhibits MARK4 activity and mitigates tau toxicity.
    Oba T; Homma D; Limlingan SJM; Fukuchi A; Asada A; Saito T; Ando K
    Neurobiol Dis; 2023 Nov; 188():106334. PubMed ID: 37884211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4.
    Khan P; Queen A; Mohammad T; Smita ; Khan NS; Hafeez ZB; Hassan MI; Ali S
    J Nat Prod; 2019 Aug; 82(8):2252-2261. PubMed ID: 31343173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism-based pharmacokinetics-pharmacodynamics studies of harmine and harmaline on neurotransmitters regulatory effects in healthy rats: Challenge on monoamine oxidase and acetylcholinesterase inhibition.
    Jiang B; Meng L; Zou N; Wang H; Li S; Huang L; Cheng X; Wang Z; Chen W; Wang C
    Phytomedicine; 2019 Sep; 62():152967. PubMed ID: 31154274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones.
    Voura M; Khan P; Thysiadis S; Katsamakas S; Queen A; Hasan GM; Ali S; Sarli V; Hassan MI
    Sci Rep; 2019 Feb; 9(1):1676. PubMed ID: 30737440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.
    Annadurai N; Agrawal K; Džubák P; Hajdúch M; Das V
    Cell Mol Life Sci; 2017 Nov; 74(22):4159-4169. PubMed ID: 28634681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of microtubule affinity-regulating kinase 4 catalytic domain in complex with a pyrazolopyrimidine inhibitor.
    Sack JS; Gao M; Kiefer SE; Myers JE; Newitt JA; Wu S; Yan C
    Acta Crystallogr F Struct Biol Commun; 2016 Feb; 72(Pt 2):129-34. PubMed ID: 26841763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.